PANCAIM

PANCAIM is a European consortium aiming to improve pancreatic cancer treatment with artificial intelligence optimizing and integrating genomics and medical imaging. The project combines genomics and imaging phenomics using AI to generate breakthrough knowledge to increase understanding of PDAC biology and patient stratification. Thereby, PANCAIM will revolutionize the care for patients with PDAC by enabling the clinicians to give the right treatment to the right patients at the right time, and at the right cost. The PANCAIM project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 101016851.